Discover key insights from Evolent Health's Q4 2024 earnings call, focusing on 30% revenue growth, contract renegotiations, projections for 2025, ...

Explore key insights from ICON's Q4 2024 earnings call, including bookings growth, digital innovation, and strategic partnerships driving 2025 growth targets.

The following nine stocks are among the best growth stocks to buy for the next 10 years, based on their wide moat, history of ...

Its dollar-based net retention rate stood at an impressive 117% in the previous quarter, as measured by the trailing-12-month ...

The broad rally for the S&P 500 index has continued so far in 2025, with a 2% increase for the large-cap U.S. benchmark index through last week. This has some investors continuing to worry that ...